Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1847023Generated: November 2, 2026

Acetic Acid → 4-(2-Fluoro-3-{[5-oxo-1-(3-oxo-3,4-dihydro-2H-1,4benzoxazin-6-yl)pyrrolidin-3-yl]amino}propyl)-6-methoxypyrido[2,3-b]pyrazin-3(4H)-one

https://huagongshe.com/reaction/1847023

Reaction equation

Participants

RoleNameHCIDCharge
ReactantAcetic AcidHCID 176—
ReactantSodium SulfateHCID 24436—
ReactantSodium triacetoxyborohydrideHCID 5049666—
Reactant6-(4-Amino-2-oxopyrrolidin-1-yl)-2H-1,4-benzoxazin-3(4H)-oneHCID 82498406—
Reactant2-Fluoro-3-(6-methoxy-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl)propanalHCID 86724951—
SolventDimethylformamideHCID 6228—
SolventDichloromethaneHCID 6344—
Product4-(2-Fluoro-3-{[5-oxo-1-(3-oxo-3,4-dihydro-2H-1,4benzoxazin-6-yl)pyrrolidin-3-yl]amino}propyl)-6-methoxypyrido[2,3-b]pyrazin-3(4H)-oneHCID 8672495041%

Reaction Steps

A crude product of 2-Fluoro-3-(6-methoxy-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl)propanal (323 mg), 6-(4-amino-2-oxopyrrolidin-1-yl)-2H-1,4-benzoxazin-3(4H)-one (Reference Example 6; 227 mg, 0.917 mmol) were mixed in a mixed solution of dichloromethane (30 ml) and N,N-dimethylformamide (3 ml). Acetic acid (0.105 ml, 1.834 mmol) and anhydrous sodium sulfate (450 mg) were added to the solution and the mixture was stirred for 12 hours. Sodium triacetoxyborohydride (389 mg, 1.834 mmol) was added to the reaction solution, the mixture was stirred for 4 hours and then the solvent was removed under reduced pressure. A lower layer solvent of chloroform/methanol/water (7:3:1) was added to the residue and the resultant was alkalized by adding saturated sodium bicarbonate water under cooling on ice. The mixture was extracted with a lower layer solvent of chloroform/methanol/water (7:3:1), the extract was dried over anhydrous sodium sulfate and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (chloroform/methanol) and preparative layer chromatography (silica gel, chloroform/methanol=20:1) to yield 180 mg (41%) of the title compound in the form of a light orange solid.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08952010B2
Source datasetuspto-grants-2015_02
ORD IDord-a73e80160a7e4dce9f79b3ec7c41d6ea
Source noteuspto-grants-2015_02